Ketamine for Thrombolysis in Acute Ischemic Stroke "KETA"

Recruiting

Phase 1/2 Results N/A

Summary of Purpose

KETA trial is a nonprofit, double-blind, randomized, controlled pilot trial with aiming to determine if co-administration of ketamine with recombinant of tissue type plasminogen activator (tPA) for thrombolysis in acute ischemic stroke compared with tPA co-administered with placebo, decreases cerebral infarction growth in diffusion weighted imaging between admission and day 1. Eligibility applies to patients with...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 23 February 2016.

1 Mar 2015 3 Oct 2014 1 Dec 2017 1 Feb 2018 1 Feb 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available